Search Result "dyslipidemia."


Treating Dyslipidemias: Is Inflammation the Missing Link?

Journal: Medicinal Chemistry
Volume: 10 Issue: 7 Year: 2014 Page: 643-652
Author(s): Nikolaos Papoutsidakis, Spyridon Deftereos, Georgios Giannopoulos, Vasiliki Panagopoulou, Antonis S. Manolis, Georgios Bouras

Medications not Intended for Treatment of Dyslipidemias and with a Variable Effect on Lipids

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6325-6338
Author(s): Thomas F. Whayne Jr, Debabrata Mukherjee

The Relationship Between Inflammation, Dyslipidemia and Physical Exercise: From the Epidemiological to Molecular Approach

Journal: Current Diabetes Reviews
Volume: 10 Issue: 6 Year: 2014 Page: 391-396
Author(s): F. S. Lira,J. C. Rosa Neto,B. M. M. Antunes,R. A. Fernandes

Effect of GLP-1 Based Therapies on Diabetic Dyslipidemia

Journal: Current Diabetes Reviews
Volume: 10 Issue: 4 Year: 2014 Page: 238-250
Author(s): Vishal J. Patel,Amit A. Joharapurkar,Gaurang B. Shah,Mukul R. Jain

Effect of Nigella Sativa and Allium Sativum Coadminstered with Simvastatin in Dyslipidemia Patients: A Prospective, Randomized, Double-Blind Trial

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2014 Page: 68-74
Author(s): Amina Hamed Ahmad Alobaidi

Hyper-Coagulable Profile with Elevated Pro-Thrombotic Biomarkers and Increased Cerebro- and Cardio-Vascular Disease Risk Exist Among Healthy Dyslipidemic Women

Journal: Current Neurovascular Research
Volume: 11 Issue: 2 Year: 2014 Page: 142-148
Author(s): Claudia N. Ferreira,Maria G. Carvalho,Helton J. Reis,Karina B. Gomes,Marinez O. Sousa,Andras Palotas

Atherogenic Versus Non-atherogenic Lipoprotein Profiles in Healthy Individuals. Is There a Need to Change Our Approach to Diagnosing Dyslipidemia?

Journal: Current Medicinal Chemistry
Volume: 21 Issue: 25 Year: 2014 Page: 2892-2901
Author(s): S. Oravec,A. Dukat,P. Gavornik,M. Kucera,K. Gruber,L. Gaspar,M. Rizzo,P.P. Toth,D.P. Mikhailidis,M. Banach

Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 5025-5038
Author(s): Ioanna Gouni-Berthold, Heiner K. Berthold

Glucagon-Like Peptide-1 as a Key Regulator of Lipid and Lipoprotein Metabolism in Fasting and Postprandial States

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 14 Issue: 2 Year: 2014 Page: 126-136
Author(s): Sarah Farr,Jennifer Taher,Khosrow Adeli

Metabolic Syndrome and Asthma

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 8 Issue: 1 Year: 2014 Page: 60-66
Author(s): Jenny V. Garmendia,Dolores Moreno,Alexis H. Garcia,Juan B. De Sanctis

Previous   Next

Go To   Results 1 - 1 of 170

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy